Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

monoclonal antibody DR-01

A human non-fucosylated immunoglobulin G1 (IgG1) monoclonal antibody directed against an as of yet undisclosed cell surface receptor expressed on cytotoxic cells, with potential immunomodulatory and antineoplastic activities. Upon administration, monoclonal antibody DR-01 binds to the as of yet undisclosed cell surface receptor expressed on cytotoxic cells and induce antibody-dependent cellular cytotoxicity (ADCC) against these cytotoxic cells. This may reduce tumor cell proliferation of certain leukemias and lymphomas, and modulate immune responses in certain autoimmune conditions.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Code name:DR 01
DR-01
DR01
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search